Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
6
Number of overlapping holdings
17.1%
% of PTH's 35 holdings also in SBIO
7.1%
% of SBIO's 90 holdings also in PTH
Overlap by Weight
Sector Drift (PTH minus SBIO)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PTH |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
AXSOME THERAPEUTICS, INC. | 3.3% | 4.4% | 3.3% |
|
PROTAGONIST THERAPEUTICS, INC. | 2.9% | 2.8% | 2.8% |
|
PTC THERAPEUTICS INC | 2.6% | 3.6% | 2.6% |
|
LIQUIDIA TECHNOLOGIES, INC. | 2.0% | 1.1% | 1.1% |
|
ANAVEX LIFE SCIENCES CORP. | 2.2% | 0.7% | 0.7% |
Position Highlights (Non-Overlapping Exposures)
PTH Overweight Relative to SBIO
|
CENCORA INC | 4.5% |
|
ELI LILLY & CO | 4.3% |
|
EXELIXIS INC | 4.0% |
|
ALIGNMENT HEALTHCARE, INC. | 3.9% |
|
TG THERAPEUTICS INC | 3.7% |
|
BOSTON SCIENTIFIC CORP | 3.6% |
|
GUARDANT HEALTH, INC. | 3.5% |
|
KRYSTAL BIOTECH, INC. | 3.5% |
|
INSMED INC | 3.4% |
|
BRIDGEBIO PHARMA, INC. | 3.3% |
PTH Underweight Relative to SBIO
 |
ALKERMES PLC | -4.1% |
|
RHYTHM PHARMACEUTICALS, INC. | -3.8% |
|
AVIDITY BIOSCIENCES INC | -3.1% |
 |
ZAI LAB LTD. UNSPONSORED ADR | -2.9% |
 |
MERUS N.V. | -2.9% |
|
AKERO THERAPEUTICS, INC. | -2.9% |
|
CRINETICS PHARMACEUTICALS INC | -2.7% |
 |
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | -2.4% |
|
ACADIA PHARMACEUTICALS INC | -2.3% |
|
AMICUS THERAPEUTICS INC | -2.0% |